Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab vs Guselkumab in Psoriasis (COBRA)
NCT04533737Phase 4Terminated
- Sponsor
- LEO Pharma
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 4 trial of brodalumab in plaque psoriasis, sponsored by LEO Pharma. Started Dec 2020; status: terminated.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04533737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04533737.